FDA delays decision on Cephalon's jet lag drug
22 December 2009
Asher Mullard
Please Login to read the full article.
22 December 2009
Asher Mullard
asher.mullard@informa.com
The US FDA has postponed the PDUFA date for an sNDA from Cephalon, requesting permission to market Nuvigil (armodafinil) for jet lag, by three months, until March 29th, 2010.
The sNDA for the drug – which was launched in the US earlier this year to improve wakefulness in patients...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: FDA's CDER ends 2011 with 30 new drugs and biologics
- 2012 patent expiries will undermine pharma industry
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
- Novartis files for approval of glycopyrronium bromide for COPD in Japan
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
